Andreas Muhler
23Patents
6h-index
26Co-inventors
69Inventor score
Filing activity: Jun 6, 1995 → Nov 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5820849A | Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 48 | Expired |
| US6248306A | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5676923A | Substituted DTPA monoamides of the central carboxylic acid group and their metal complexes | Chemistry; Metallurgy | 10 | Expired |
| US5874061A | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Human Necessities | 7 | Expired |
| US5759518A | Metal complexes of dendrimeric macromolecules, diagnostics agents that contain the latter as well as process for the production of the complexes and agents | Chemistry; Metallurgy | 7 | Expired |
| US5746995A | DTPA derivatives substituted in a novel way, their metal complexes, and their use in diagnosis and therapy | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5853699A | Use of tetra azacycle complexes as x-ray diagnostic agents for the liver and gallbladder | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5733522A | Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use and process for their production | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5885548A | Multiply substituted DTPA derivatives and their metal complexes, and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6063361A | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6057419A | Cascade polymer complexes, process for producing the same and pharmaceuticals containing the same | Human Necessities | 3 | Expired |
| US5672335A | Use of metal complexes as liver and gallbladder X-ray diagnostic agents | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5730956A | DTPA di-alkyl monoamides for x-ray and MRI | Chemistry; Metallurgy | 1 | Expired |
| US11376232B2 | Vidofludimus for use in the treatment or prevention of viral diseases | Chemistry; Metallurgy | 1 | Active |
| US6177060A | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7211241B2 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US12167994B2 | Vidofludimus for use in the treatment or prevention of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US11877994B2 | Treatment of multiple sclerosis comprising DHODH inhibitors | Human Necessities | 0 | Active |
| US6426059B1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US12037305B2 | Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents | Chemistry; Metallurgy | 0 | Active |
| US6166200A | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Chemistry; Metallurgy | 0 | Expired |
| US6861043B2 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11877995B2 | Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.